Clinical trial
Combination Chemotherapy in Treating Patients With Stage III or Stage IV…
NCT00004003 · Barbara Ann Karmanos Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00004003 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Stage III or Stage IV Pancreatic Cancer That Cannot Be Removed by Surgery |
| Official title | A Study of Gemcitabine, Cisplatin, and 5-Fluorouracil in the Treatment of Advanced Pancreatic Cancer |
| Lead sponsor | Barbara Ann Karmanos Cancer Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Drug |
| Interventions | cisplatin, fluorouracil, gemcitabine hydrochloride |
| Enrollment | 30 |
| Start date | Apr 1, 1999 |
| Primary completion | Nov 1, 2001 |
| Completion | Aug 1, 2003 |
| First posted | Feb 12, 2004 |
| Last update posted | Apr 5, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: